Sunday, January 7, 2007

The Gloucester Sailboat

BEFORE THE LAW OF THE RETINA May 18, 2001 WAS NOT DESERVING OF EXEMPTIONS considered a disease, was not considered highly disabling

IL MINISTRO DELLA SANITÀ
VISTO il decreto legislativo 29 aprile 1998, n.124, avente ad oggetto "Ridefinizione del sistema di partecipazione al costo delle prestazioni sanitarie e del regime delle esenzioni, a norma dell'articolo 59, comma 50, della legge 27 dicembre 1997, n. 449", pubblicato nella Gazzetta Ufficiale n. 99 del 30 aprile 1998, e in particolare l'articolo 5, comma 1, lettera b) e comma 5, che prevede che il Ministro della sanità, con distinti regolamenti da emanarsi ai sensi dell'articolo 17, comma 3, della legge 23 agosto 1988, n.400, individui, rispettivamente, le condizioni di malattia croniche o invalidanti e le malattie rare che danno diritto all'esenzione dalla partecipazione per le prestazioni di assistenza sanitaria indicate dai medesimi regolamenti;
VISTO il decreto ministeriale 1 febbraio 1991 avente concerning "Reassessment of these diseases, entitlement to the exemption from health costs" and subsequent amendments and additions; VISTA
the Law of 31 December 1996, no 675 and subsequent amendments and the enactment May 11, 1999, No 135 and July 30, 1999, No 282, concerning the confidentiality of personal data;
CONSIDERING the decree of the President July 28, 1999, No 318, laying down rules for the identification of minimum security measures for the processing of personal data in accordance with Article 15, paragraph 2 of law No. 675 of 1996, as amended;
After consulting the Board of Health at its meeting on 25 November 1998; VISA
the opinion of the Permanent Conference for Relations between State, Regions and Autonomous Provinces of Trento and Bolzano, made at its meeting on May 27, 1999;
GIVEN the opinion of the Guarantor for the protection of personal data, made on October 27, 1999; INCORPORATED
that opinion on the measures to be taken for collection, processing, storage, preservation and security of data and in terms of characteristics and operating procedures of the National Register of Rare Diseases;
the VISA opinion of the Permanent Conference for Relations between State, Regions and Autonomous Provinces of Trento and Bolzano, made at its meeting on 1 February 2001, the amended text as a result of the findings Guarantor for the protection of personal data;
heard the opinion of the State Council, expressed by the advisory section for legal acts in the meeting of March 26, 2001;
VISTA note of communication to the President of the Council of Ministers no 100/SCPS/2153-G/2482 of May 2, 2001, pursuant to art. 17, paragraph 3 of Law August 23, 1988, No 400;
CONSIDERED predict the entry into force of this Regulation as from the date of its publication in the Official Gazette of the Italian Republic, in view of the long and complex process required for its approval
adopted the following rules
Art.1
Aims and scope
1. The presente regolamento disciplina le modalità di esenzione dalla partecipazione al costo delle malattie rare per le correlate prestazioni di assistenza sanitaria incluse nei livelli essenziali di assistenza, in attuazione dell'articolo 5 del
decreto legislativo 29 aprile 1998, n.124 , e individua specifiche forme di tutela per i soggetti affetti dalle suddette malattie.
Art. 2
Rete nazionale per la prevenzione, la sorveglianza, la diagnosi e la terapia delle malattie rare
1. Al fine di assicurare specifiche forme di tutela ai soggetti affetti da malattie rare è istituita la Rete nazionale per la prevenzione, la sorveglianza, la diagnosi e la terapia delle malattie rare. The network consists of principals credited the designated regions. Under these safeguards, preferably hospital by the Minister of Health on a proposal from the region concerned, in consultation with the Permanent Conference for relations between the state, regions and autonomous provinces of Trento and Bolzano on the basis of criteria for identifying and updating were conducted with the same conference, identifying the inter-regional Centres of Reference for rare diseases. The regions shall identify the principals and the formulation of proposals, for the first time, respectively, within forty-five to sixty days from the date of entry into force of this Regulation. In the next ninety days, the Minister of Health of the Centers shall identify interregional riferimento.2. Principals of the network are identified from among those in possession of documented experience in diagnostic or therapeutic activity for specific diseases or groups of rare diseases, as well as provision of appropriate support structures and complementary services, including, for diseases that require, for the emergency services and diagnostic biochemical and genetic - molecolare.3. The centers provide inter-related, each to the territorial area of \u200b\u200bcompetence, the performance of the following functions: a) the management of inter-registry of rare diseases, with matching records and the local National Register referred to in Article 3, b) the exchange of information and documentation on rare diseases with other centers and inter relevant international bodies; c) the coordination of principals of the Network in order to ensure early diagnosis and the ' appropriate therapy, if any, through the adoption of specific protocols agreed d) advice and support to the National Health Service doctors in order to rare diseases and the availability of appropriate drugs for their treatment, e) collaboration with training of health professionals and voluntary initiatives and preventive f) information to citizens and associations of patients and their families in order rare diseases and the availability of farmaci.4. The tools included in the network operate according to clinical protocols agreed with the centers of inter-related and work with local services and family doctors to the detection and management of trattamento.5. The Minister of Health to ensure the dissemination of the national list of medical devices in the network and report on its activities in the Report on the health status of the country referred to in Article 1, paragraph 6 of Legislative Decree No 30 December 1992 502, as amended. Article 3
National Register
1. In order to allow national and regional programs of action to alla tutela dei soggetti affetti da malattie rare e di attuare la sorveglianza delle stesse è istituito presso l'Istituto Superiore di Sanità il Registro nazionale delle malattie rare.2. Il Registro raccoglie dati anagrafici, anamnestici, clinici, strumentali, laboratoristici e relativi ai fattori di rischio e agli stili di vita dei soggetti affetti da malattie rare, a fini di studio e di ricerca scientifica in campo epidemiologico, medico e biomedico.3. Il Registro nazionale è funzionalmente collegato con i registri interregionali e territoriali e, ove esistenti, con i registri internazionali.4. La raccolta dei dati e il loro trattamento, consistente nelle operazioni di validazione, analisi statistico-epidemiologica, valutazione delle associazioni tra risk factors and lifestyle-related etiology and prognosis, updating, integration and eventual cancellation, shall be made in accordance with the existing legislation on data protection personali.5. The access and processing of data is permitted in accordance with applicable regulations regarding the protection of personal data and the adoption of security measures in the decree of the President July 28, 1999, No 318. Data access is also permitted operators of the centers of reference specifically authorized for the purposes of article 2, paragraph 3.6. The health data are stored in paper files and computer separately from any other personal data are processed and con tecniche di cifratura o codici identificativi che consentano di identificare gli interessati solo in caso di necessità.7. La comunicazione e la diffusione dei dati del Registro nazionale è consentita per le finalità e nei limiti di cui all'art. 21, comma 4, lettera a), della legge 31 dicembre 1996 n. 675, e successive modificazioni.8. Il trasferimento all'estero dei dati del Registro nazionale è consentito ai sensi dell' art. 28, comma 4, lettera g-bis, della legge 31 dicembre 1996 n. 675 e successive modificazioni e integrazioni.9. Le disposizioni del presente articolo si applicano anche ai registri interregionali tenuti dai Centri di riferimento di cui all'articolo 2, comma 3.
Art. 4
Individuazione
a rare disease. Annex 1, which forms an integral part of this Regulation, a list of diseases and groups of rare diseases for which it is entitled to exemption from participation in the cost of the related health care benefits and a statement the most frequently used synonyms diagnosed illnesses. To allow the unique identification of rare diseases for the purposes of the exemption, each disease or group of diseases is associated with a specific identification code. Article 5
Diagnosis of the disease and recognition of the right of exemption
1. The medium for which it was formulated by a medical specialist in the Health Service the national suspected diagnosis of a rare disease listed in Annex 1 is directed by the same physician, according to the information center of the appropriate inter-reference to the principals of the network can guarantee the detection of specific disease or group of malattie.2 . Principals ensure the delivery of the Network pursuant to an exemption from participation in the cost of benefits for the diagnosis and, if necessary for the diagnosis of rare hereditary disease, the genetic testing on family members assisted. The related charges are the sole responsibility of the local health unit of residence of the assisted .3. Principals Network report any new case of rare disease known at the center reference jurisdiction, as stipulated in special technical specifications prepared by the Superior Sanità.4. The medium that has been established by a garrison of the network a rare disease listed in Annex 1 may apply for recognition of exemption law firm local public health unit of residence, attaching a certificate issued by the garrison stesso.5. At the time of issuance of the certificate of exemption, the company provides to the interested local health information in accordance with Articles 10 and 23 of Law No 31 December 1996 675, as amended, and acquires the written consent to the processing of data by providers of services, public agreement or accredited by the National Health Service, with regard to prescribing and dispensing of medical services under the esenzione.6. The collection and processing of data, consisting of the registration operations, validation, updating, integration and eventual cancellation, shall be made in accordance with the existing legislation on data protection personali.7. Access and data processing companies are allowed to the operators of local health units authorized for that purpose, in accordance with applicable regulations regarding the protection of personal data and the adoption of security measures in the decree of the President of the Republic 28 July 1999, no 318, for the recognition of the right exemption and the control of the exemptions granted, for administrative-accounting for the control of its expenditure from the national health service and the quality and appropriateness of care erogata.8. The health data are stored in paper files and computer separately from all other personal and are treated with encryption techniques or identification codes that allow identifying data subjects only if necessità.9. The communication and dissemination of information referred to in this Article shall be subject to the provisions of Art. 27 of Law No 31 December 1996 675, as amended. Article 6
delivery mechanisms delle prestazioni
1. L'assistito riconosciuto esente ha diritto alle prestazioni di assistenza sanitaria, prescritte con le modalità previste dalla normativa vigente, incluse nei livelli essenziali di assistenza, efficaci ed appropriate per il trattamento ed il monitoraggio della malattia dalla quale è affetto e per la prevenzione degli ulteriori aggravamenti.2. Gli assistiti esenti dalla partecipazione al costo ai sensi del presente regolamento e ai sensi del decreto ministeriale 28 maggio 1999, n. 329, sono altresì esentati dalla partecipazione al costo delle prestazioni necessarie per l'inclusione nelle liste di attesa per trapianto.3. Ferme restando le competenze della Commissione unica del farmaco di cui all'articolo 7 del decreto legislativo 30 June 1993 No 266, as amended, the regions, based on the needs of its population, establish procedures for the acquisition and distribution to interested parties of certain drugs, including the direct provision of pharmaceutical services by the public. Article 7
prescribing performance
1. The limitation of health benefits payable pursuant to an exemption from participation in the cost under this regulation, shall be designated, only in coded form in accordance with Article 4 of the rare disease for which he is entitled to exemption. 2. Except to the extent of prescribing under the current regulations, ciascuna ricetta non può contestualmente recare la prescrizione di prestazioni erogabili in regime di esenzione dalla partecipazione al costo e di altre prestazioni.3. La prescrizione delle prestazioni erogabili in esenzione dalla partecipazione al costo è effettuata secondo criteri di efficacia e di appropriatezza rispetto alle condizioni cliniche individuali, con riferimento ai protocolli, ove esistenti, definiti dai Centri di riferimento e in collaborazione con i presidi della Rete.
Art. 8
Aggiornamento
1. I contenuti del presente regolamento sono aggiornati, con cadenza almeno triennale, con riferimento all'evoluzione delle conoscenze scientifiche e tecnologiche, ai dati epidemiologici relativi alle malattie rare and development of diagnostic and therapeutic referred to in Article 1, paragraph 28 of the Law of 23 December 1996 662, as amended and supplemented. Article 9
and Provisional Rules
1. From the entry into force of this regulation subjects recognized exempt under
Ministerial Decree of 28 May 1999, no 329 , with: Budd-Chiari syndrome, hereditary anemia, mixed connective tissue, primary immunodeficiencies, with Lennox-Gastaut syndrome, congenital disorders of lipoprotein metabolism (except: heterozygous familial hypercholesterolemia type IIa and IIb primary hypercholesterolaemia polygenic, Hypercholesterolemia family combined hyperlipoproteinemia type III), hereditary coagulation defects, Huntington's Disease, Polyarteritis nodosa, included in Annex 1 to this Regulation, are entitled to exemption from participation in the cost of benefits provided for in Article 6 of this Regulation .2. Annex 1 to Ministerial Decree of 28 May 1999, no 329 , is amended as set out in Annex 2, which form an integral part of this regolamento.3. From the entry into force of this Regulation who are already exempt under the Ministerial Decree of February 1, 1991, published in the Official Gazette of February 7, 1991, as amended and supplemented, for hereditary angioedema, dermatomyositis, pemphigus and pemphigoid, congenital anemia, and inborn errors of metabolism, phenylketonuria, congenital myopathies, Hansen's disease, Turner syndrome, and spasticity from cerebrovascular Retinitis pigmentosa, are entitled to exemption from participation in the cost of benefits under Article 6 of this regolamento.4. Companies local health units, notwithstanding the provisions of Article 5, adjust the claims of exemption relating to the diseases referred to in paragraphs 1 and 3 as provided for in this Regulation for diseases corrispondenti.5. From the entry into force of this Regulation shall cease to have effect to the provisions of Articles 1, 2, 3 and 4 decreto ministeriale 1° febbraio 1991, pubblicato sulla Gazzetta Ufficiale del 7 febbraio 1991, e successive modifiche e integrazioni.6. Le aziende unità sanitarie locali provvedono a comunicare ai medici di medicina generale ed ai pediatri di libera scelta i contenuti del presente regolamento e le specifiche modalità di applicazione.7. Le disposizioni del presente regolamento saranno adeguate sulla base della disciplina da emanarsi ai sensi dell'articolo 6 del decreto legislativo 29 aprile 1998, n. 124, ove venga meno la sospensione dell'efficacia fissata dall'articolo 84 della legge 23 dicembre 2000, n. 388, nonché della disciplina da emanarsi ai sensi dell'articolo 23 della legge 31 dicembre 1996, n. 675, come modificata dal decreto legislativo 30 luglio 1999, n. 282.8. Il presente regolamento entra in vigore a decorrere dalla data di pubblicazione nella Gazzetta Ufficiale della Repubblica Italiana.
Il presente regolamento, munito del sigillo dello Stato, sarà inserito nella Raccolta ufficiale degli atti normativi della Repubblica Italiana. E' fatto obbligo a chiunque spetti di osservarlo e di farlo osservare.
Elenco alfabetico delle malattie incluse nei gruppi
Definizione malattia e/o gruppo (comprende i sinonimi)
Codice Esenzione
AARSKOG SINDROME DI
RN0790
AASE-SMITH SINDROME DI
RN1340
ACALASIA
RI0010
ACERULOPLASMINEMIA CONGENITA
RC0120
ACROCEFALOSINDATTILIA
RNG030
ACRODERMATITE ENTEROPATICA
RC0070
Acrodysostosis
RN0280
ADAMS-OLIVER SYNDROME
RN0340
ADIPOSE PAINFUL
RC0090 RF0120
adrenoleukodystrophy

Agenesis CEREBELLAR

RN0030 RN1350

Alagille Syndrome Alpers Disease
RF0010
Alport Syndrome Alström Syndrome

RN1360
RN1370
congenital OF IRON METABOLISM
RCG100
congenital abnormalities of lipoprotein metabolism included: heterozygous familial hypercholesterolemia type IIa and IIb primary polygenic hypercholesterolemia, familial combined hypercholesterolemia, hyperlipoproteinemia type III.
RCG070
OTHER MULTIPLE CONGENITAL ANOMALIES WITH MENTAL RETARDATION
RNG100
PRIMARY AMYLOIDOSIS AND FAMILY
RCG130
ANEMIAS HEREDITARY
RDG010
Angelman Syndrome
RN1300
ANGIOEDEMA CROWN RC0190

aniridia
RN0110 RN0190
imperforate anus

CONGENITAL ANOMALIES OF SKULL AND / OR BONE FACE
RNG040
Antley -Bixler Syndrome

RN0800 RN0640 aplasia cutis congenita

INFANTILE APNEA
RP0050
Arnold-Chiari Syndrome
RN0010
giant cell arteritis
RG0080
arthrogryposis multiplex congenita
RNG020
asplenia with cardiovascular anomalies
RN0740
ATRANSFERRINEMIA CONGENITAL
RC0130
biliary atresia

RN0210 Atresia FASTING
RN0170
esophageal atresia and / or fistula Tracheoesophageal atresia or stenosis

RN0160 RN0180 DUODENAL

ATROPHY TOOTHED RUBROPALLIDOLUYSIANA
RF0050
hemifacial ATROPHY PROGRESSIVE ESSENTIAL ATROPHY OF THE IRIS
RN0650


RF0240 RF0300 Leber optic atrophy

spinal muscular atrophies
RFG050
Axenfeld-Rieger FAULT
RN0090
Baller-Gerold Syndrome
RN0810
Bardet-Biedl Syndrome
RN1380
BECKWITH-WIEDEMANN SYNDROME
RN0820
Behcet Disease
RC0210
BEHR SYNDROME
RF0220
Bloch-Sulzberger DISEASE
RN1480 RN0830

BLOOM SYNDROME
BLUE RUBBER BLEB NEVUS
RN0150
BORJESON SINDROME DI
RN0840
BUDD-CHIARI SINDROME DI
RG0110
CAMPTODATTILIA FAMILIARE
RN0290
CARENZA CONGENITA DI ALFA1 ANTITRIPSINA
RC0200
CAROLI MALATTIA DI
RN0220
CARPENTER SINDROME DI
RN1390
CEROIDO-LIPOFUSCINOSI
RFG020
CHARGE ASSOCIAZIONE
RN0850
CHAVANY-MARIE SINDROME DI
RN0070
CHEDIAK-HIGASHI MALATTIA DI
RD0060
CHERATITE-ITTIOSI-SORDITA'
RN1500
CHERATOCONO
RF0280
CHERATOSI FOLLICOLARE ACUMINATA
RN0530
CHIRAY FOIX SINDROME DI
RN0070
CHURG-STRAUSS SINDROME DI
RG0050
CICLITE ETEROCROMICA DI FUCH
RF0230
Interstitial Cystitis
RJ0030
COATS DISEASE
RF0200
COCKAYNE SYNDROME
RN1400
COFFIN-LOWRY SYNDROME Coffin-Siris
RN0350

RN0360
COGAN SYNDROME SYNDROME
RF0270
cholangitis PRIMITIVE SCLEROSING
RI0050
Coloboma CONGENITAL OPTICAL DISC
RN0120
chondrodystrophy CONGENITAL
RNG050
ligneous conjunctivitis
RF0290 RM0030


mixed connective undifferentiated
RMG010
Huntington
RF0080
CORNELIA DE LANGE SYNDROME
RN1410
craniosynostosis - midfacial hypoplasia - foot anomalies

RN0400 CRI DU CHAT DISEASE
RN0670
Crigler-Najjar Syndrome

mixed cryoglobulinemia
RC0180 RC0110
CRISWICK-SCHEPENS SYNDROME
RF0200
Cronkhite-Canada Disease
RB0030
Telangiectases CONGENITAL SKIN MARBLE

cutis laxa
RN0540 RN0500 RN0550
Darier Disease

DE Morsier SYNDROME
RN0860
De Sanctis Cacchione DISEASE
RN1420
CONGENITAL DEFICIENCY OF ZINC

ACTH deficiency
RC0070 RC0010 RC0100

ceramidase deficiency
deformations' Sprengel
RN0270
DEGENERATION hepatocerebral
RC0150
LENTICULAR DEGENERATION OR FAMILY PUTAMINALE
RC0150
DEGENERATION OF THE CORNEA
RFG130
Denys-Drash Syndrome
RN1430
DERCUM DISEASE
RC0090
dermatitis herpetiformis Dermatomyositis


RL0020 RM0010
nephrogenic diabetes insipidus
RJ0010
DEFECTS HEREDITARY COAGULATION
RDG020
familial dysautonomia
RN0080 RN0560
dyskeratosis congenita

DISFAGOCITOSI CHRONIC
RD0050
Metabolism of purine and pyrimidine
RCG120
dysplasia oculo-DIGITO-DENTAL DYSPLASIA

RN1440 RN0860

septo-optic dysplasia spondyloepiphyseal dysplasia
spondylocostal
RN0410 RN1450
dystonia
CONGENITAL IDIOPATHIC TORSION
RF0090
DYSTROPHIES HEREDITARY CORNEAL
RFG140
DYSTROPHIES HEREDITARY choroidal
RFG120
DYSTROPHIES MYOTONIC
RFG090
muscular dystrophies
RFG080
Hereditary retinal dystrophies
RFG110
DISORDERS lipid storage
RCG080
urea cycle disorders
RCG050
DISORDERS OF METABOLISM AND THE amino acid transport
RCG040
DISORDERS OF THE METABOLISM AND TRANSPORT OF CARBOHYDRATES Excluded: diabetes mellitus
RCG060
DONHOUE SYNDROME DOWN SYNDROME
RC0050

RN0660 RN0870
Dubowitz Syndrome

Dyggve-Melchior-Clausen (DMC) SYNDROME
RN0370
Eales Disease
RF0210
EATON-LAMBERT SYNDROME
RF0190
ECTRODATTILIA - DISPLASIA ECTODERMICA - PALATOSCHISI
RN0880
EDEMA ANGIONEUROTICO EREDITARIO
RC0190
EEC SINDROME
RN0880
EHLERS-DANLOS SINDROME DI
RN0330
EMBRIOFETOPATIA RUBEOLICA
RP0010
EMERALOPIA CONGENITA
RF0250
EMOGLOBINURIA PAROSSISTICA NOTTURNA
RD0020
ENDOCARDITE REUMATICA
RG0010
EPIDERMOLISI BOLLOSA
RN0570
EPILESSIA MIOCLONICA E FIBRE ROSSE IRREGOLARI
RN0720
EPILESSIA MIOCLONICA PROGRESSIVA
RF0060
ERITROCHERATODERMIA SIMMETRICA PROGRESSIVA
RN0580
ERITROCHERATODERMIA VARIABILE
RN0590
ERITROCHERATOLISI HIEMALIS
RL0010
ERITRODERMA ITTIOSIFORME CONGENITO True Hermaphroditism
Bullosa
RN0600 RN0240

phacomatosis
RN0750
FARBER DISEASE
RC0100
fasciitis eosinophilic fasciitis


RM0050 RM0040
congenital hepatic fibrosis
RP0070
fibrosis
RJ0020
FILIPPI SYNDROME

Phocomelia
RN0380 RN0260
FOSFOETILAMINURIA
RC0160
FRASER SYNDROME
RN1460
FREEMAN-SHELDON SYNDROME SYNDROME Fryns

RN0890 RN0900

Ganglioside
RFG030
GARDNER'S SYNDROME
GIANT HYPERTROPHIC GASTRITIS RB0040

RI0020 RI0030
eosinophilic gastroenteritis

gastroschisis
RN0320
GERSTMANN SYNDROME SYNDROME
RQ0010
GOLDENHAR
RN0910
Goodpasture Syndrome Wegener's granulomatosis

RG0060 RG0070

GREIG'S SYNDROME, cephalopolysyndactyly
RN0390
HANSEN'S DISEASE
RA0010
HAY-WELLS SYNDROME
RN1470
Hermansky-Pudlak Syndrome Hirschsprung Disease

RN0920 RN0200

HOLT-ORAM SYNDROME
RN0930
HORTON'S DISEASE
RG0080
IDIOCY xeroderma
RN1420
PRIMARY IMMUNODEFICIENCY
RCG160
Incontinentia pigmenti
RN0510
primary aldosteronism
RCG010
epidermolytic hyperkeratosis
RN0600
hypophosphatasia
RC0160
Hypogonadism CON ANOSMIA
RC0020
IPOMELANOSI DI ITO
RN1480
IPOPLASIA FOCALE DERMICA
RN0610
ISAACS SINDROME DI
RN1490
ISTIOCITOSI CRONICHE
RCG150
ITTIOSI CONGENITE
RNG070
IVEMARK SINDROME DI
RN0740
JACKSON-WEISS SINDROME DI
RN0400
JARCHO-LEVIN SINDROME DI
RN0410
JOUBERT SINDROME DI
RN0040
KABUKI SINDROME DELLA MASCHERA
RN0940
KALLMANN SINDROME DI
RC0020
KARTAGENER SINDROME DI
RN0950
KAWASAKI SINDROME DI
RG0040
KEARNS-SAYRE SINDROME DI
RF0020
KERNITTERO
RP0060
KID SINDROME
RN1500
KLINEFELTER SINDROME DI
RN0690
KLIPPEL-FEIL SYNDROME
RN0310
Klippel-Trenaunay Syndrome
RN1510
Landau-Kleffner Syndrome
RN1520
LAWRENCE-MOON SYNDROME
RN1380
LEIGH DISEASE

LENNOX RF0030 RF0130

Gastaut Syndrome LEOPARD SYNDROME
RN1530
leprechaunism
RC0050
LEUKODYSTROPHY
RFG010
HOLLISTER-LEVY SYNDROME
RN1540
LICHEN sclerosus ET ATROPHICUS
RL0060
intestinal lymphangiectasia
RI0080
LINFOANGIOLEIOMATOSI PULMONARY
RB0060 RB0060
LINFOANGIOLEIOMIOMATOSI

Lipodystrophy Lipodystrophy
TOTAL INTESTINAL
RA0020 RC0080

Lissencephaly
RN0050
LYME DISEASE OF
RA0030
MAFFUCCI SINDROME DI
RN0960
MALATTIA DA INCLUSIONE DEI MICROVILLI
RI0070
MALATTIA DEL FEGATO POLICISTICO
RN0230
MALATTIA GRANULOMATOSA CRONICA
RD0050
MALATTIE SPINOCEREBELLARI
RFG040
MARCHIAFAVA-MICHELI SINDROME DI
RD0020
MARFAN SINDROME DI
RN1320
MARSHALL SINDROME DI
RN0970
MARSHALL-SMITH SINDROME DI
RN1550
MECKEL SINDROME DI
RN0980
MELAS SINDROME
RN0710
MELKERSSON-ROSENTHAL SINDROME DI
RF0160
MERRF SINDROME
RN0720
MICROANGIOPATIE TROMBOTICHE
RGG010
MICROCEFALIA
RN0020
MIOCLONO ESSENZIALE EREDITARIO
RF0070
MIOPATIA MITOCONDRIALE - ENCEPHALOPATHY - Lactic acid - STROKE
RN0710
MYOPATHY CONGENITAL HEREDITARY
RFG070
MOEBIUS SYNDROME MORNING GLORY

RN0990 RN0130 FAULT

MUCOLIPIDOSI
RCG090
MUCOPOLYSACCHARIDOSES
RCG140
Nager Syndrome
RN1000
narcolepsy
RF0150
nephroblastoma
RB0010 NEU-
Laxova SYNDROME
RN1560 RN1570
neuroacanthocytosis

neurofibromatosis
RBG010
hereditary optic neuropathy
RF0300
HEREDITARY NEUROPATHY
RFG060
cyclic neutropenia
RD0040
NOONAN SYNDROME

Norra RN1010 RN1580
Oguchi
DISEASE SYNDROME
RF0260
holoprosencephaly
RN0060
ONICOOSTEODISPLASIA EREDITARIA
RN1190
OPITZ SINDROME DI
RN1020
OSTEODISTROFIE CONGENITE
RNG060
PACHIDERMOPERIOSTOSI
RN0620
PALLISTER- HALL SINDROME DI
RN1030
PALLISTER-KILLIAN SINDROME DI
RN1590
PALLISTER-W SINDROME DI
RN0420
PARALISI NORMOKALIEMICHE, IPO E IPERKALIEMICHE
RFG100
PARALISI SOPRANUCLEARE PROGRESSIVA
RF0170
PARRY-ROMBERG SINDROME DI
RN0650
PEARSON SINDROME DI
RN1600
PEMFIGO
RL0030
PEMFIGOIDE BENIGNO DELLE MUCOSE
RL0050
PEMFIGOIDE BOLLOSO
RL0040
PENA-SHOKEIR I SINDROME DI
RN1110
PENA-SHOKEIR II SINDROME DI
RN1640
PERSISTENZA DELLA MEMBRANA PUPILLARE
RN0140
PETER ANOMALIA DI
RN0100
PEUTZ-JEGHERS SINDROME DI
RN0760
PFEIFFER SINDROME DI
RN1040
PIASTRINOPATIE EREDITARIE
RDG030
POEMS SINDROME
RN1610
POLAND SINDROME DI
RN0430
POLIANGIOITE MICROSCOPICA
RG0020
POLIARTERITE MICROSCOPICA
RG0020
POLIARTERITE NODOSA
RG0030
POLICONDRITE
RM0060
POLIENDOCRINOPATIE AUTOIMMUNI
RCG030
POLIMIOSITE
RM0020
POLINEUROPATIA CRONICA INFIAMMATORIA DEMIELINIZZANTE
RF0180
POLIPOSI FAMILIARE
RB0050
PORFIRIE
RCG110
PORPORA DI HENOCH-SCHONLEIN RICORRENTE
RD0030
Prader-Willi Syndrome
RN1310
pseudohermaphroditism
RNG010
pseudoxanthoma elasticum
RN0630
PUBERTY 'EARLY IDIOPATHIC
RC0040
hypophosphatemic rickets vitamin D-resistant

RC0170 RC0030

Reifenstein Syndrome Rendu-Osler-Weber
RG0100
KIDNEY DISEASE medullary sponge
RN0250
retinoblastoma
RB0020
RETT SYNDROME
RF0040
RIEGER SYNDROME
RN1050
RILEY-DAY SYNDROME

ROBERTS SYNDROME
RN0080 RN1060 RN1070


Robinow Syndrome Rubinstein-Taybi Syndrome

RN1620 RUSSELL-SILVER SYNDROME
RN1080
Schilder Disease
RF0120
Schinzel-Giedion Syndrome
RN1090
AMYOTROPHIC LATERAL SCLEROSIS PRIMARY LATERAL SCLEROSIS

RF0100 RF0110

SCLEROSIS TUBEROSA
RN0750 RN1100
Seckel Syndrome

SEQUENCE OF FETAL hypokinesia

SEQUENCE sirenomelia
RN1110 RN0440 RN0730


SHORT SYNDROME Simpson-Golabi-Behmel Syndrome
RN1120 RN1630

Acrocallosal
SYNDROME FETAL ALCOHOL SYNDROME SYNDROME FLOCKS

RP0040-oculo-Facial Syndrome FLOCKS

RN1130-RN1140

Oto-Renal Syndrome Cardio-Facio-Cutaneous
RN1150
BRAIN SYNDROME -COST-MANDIBULAR SYNDROME
RN0450
Cerebro-oculo-facio-skeletal
RN1640
insensitivity syndrome 'Partial Androgen
RC0030
SYNDROME intestinal pseudo-obstruction
RI0040
caudal regression syndrome

RN0300 RN1330
FRAGILE X SYNDROME
nevus syndrome Dysplastic

RN1650 RN1660
Epidermal nevus syndrome
SYNDROME RED NUCLEUS OF HIGHER
RN0070
hemolytic uremic syndrome
RD0010
femoral FACIAL SYNDROME
RN0460
Foetal VPA

RP0020 RP0030 fetal hydantoin syndrome

SYNDROME tears-headset-Dent-DIGITAL SYNDROME OCULO

RN1540-BRAIN
RN1160-SKIN SYNDROME
OTO-PALATE-DIGITAL SYNDROME

RN0470 PROTEO
RN1170
SINDROME PTERIGIO MULTIPLO
RN1670
SINDROME TRICO-DENTO-OSSEA
RN1680
SINDROME TRICO-RINO-FALANGEA
RN1180
SINDROME TRISMA PSEUDOCAMPTODATTILIA
RN0480
SINDROME TROMBOCITOPENICA CON ASSENZA DI RADIO
RN1690
SINDROME UNGHIA-ROTULA
RN1190
SINDROMI ADRENOGENITALI CONGENITE
RCG020
SINDROMI DA ANEUPLOIDIA CROMOSOMICA
RNG080
SINDROMI DA DUPLICAZIONE/DEFICIENZA CROMOSOMICA
RNG090
SJÖGREN-LARSSON SINDROME DI
RN1700
SMITH-LEMLI-OPITZ, TIPO 1 SINDROME DI
RN1200
SMITH-MAGENIS SINDROME DI
RN1210
SPRUE CELIACA
RI0060
STEELE-RICHARDSON-OLSZEWSKI SINDROME DI
RF0170

RN1220
Stickler Syndrome Sturge-Weber Syndrome

SUMMIT RN0770 RN1230
TAKAYASU
SYNDROME DISEASE
RG0090
TAY SYNDROME
RN1710
Telangiectases HEREDITARY HEMORRHAGIC
RG0100
TOURAINE-salento-GROOVES 'SYNDROME
RN0620 Townes-Brocks Syndrome

RN1240
PRIMARY HEREDITARY THROMBOCYTOPENIA
RDG040
Wilms tumor - aniridia - disorders GENITO - MENTAL RETARDATION
RN1730
Wilms' tumor and pseudohermaphroditism

TURNER SYNDROME
RN1430 RN0680 RN1250
VACTERL ASSOCIATION

vitreoretinopathy EXUDATIVE FAMILY
RF0200
Vogt-Koyanagi-Harada Syndrome
RN1720
von Hippel-Lindau Syndrome WAGR SYNDROME

RN0780 RN1730

WALDMANN DISEASE
RC0140
WALKER-WARBURG SYNDROME
RN1740 RN0490
WEAVER SYNDROME

MARCHESANI-WEILL SYNDROME
RN1750
WERNER SYNDROME
RC0060
WEST SYNDROME
RF0140
Whipple Disease
RA0020
WILDERVANCK SYNDROME WILLIAMS SYNDROME

RN1260 RN1270

WILMS TUMOR WILSON'S DISEASE

RB0010 RC0150

WINCHESTER SYNDROME
RN1280
Wolf-Hirschhorn Syndrome
RN0700
WOLFRAM SYNDROME
RN1290 RN0520
xeroderma pigmentosum

ZELLWEGER SYNDROME
RN1760
Alphabetical list of rare diseases, including disease-free
Definition Code Exemption

Synonym
abetalipoproteinemia
RCG070
Bassen KORNZWEIG ORGANIC SYNDROME
acidemia and lactic acid PRIMITIVE
RCG040

achondrogenesis
RNG050

ACHONDROPLASIA
RNG050

agammaglobulinemia
RCG160

ALANINEMIA
RCG040

ALBINI
RCG040

alkaptonuria
RCG040

ALEXANDER DISEASE
RFG010

Leber congenital amaurosis
RFG110

sickle cell disease
RDG010

sideroblastic anemia
RDG010
OPEN
SYNDROME
RNG030

HEREDITARY CEREBELLAR ATAXIA OF MARIE
RFG040
CEREBELLAR DEGENERATION OF MARIE
FA
RFG040

-LIKE ATAXIA Friedreich
RFG040
FAMILIAL DEFICIENCY OF VITAMIN E

RFG040
PERIODIC ATAXIA ATAXIA ATAXIA VESTIBULOCEREBELLARE
telangiectases
RFG040
LOUIS BAR SYNDROME
Bartter Syndrome
RCG010

BATTEN DISEASE
RFG020

BECKER DYSTROPHY OF
RFG080

BERNARD SOULIER SYNDROME
RDG030

Blackfan-Diamond anemia
RDG010
ANEMIA CONGENITAL hypoplastic
C SYNDROME
RNG040

CANAVAN DISEASE
RFG010

Charcot Marie Tooth Disease
RFG060
peroneal muscular atrophy
CYSTINE
RCG040

CITRULLINEMIA
RCG050

COGAN DYSTROPHY OF CORNEAL DYSTROPHY
RFG140
FRONT COMPLEX
THROMBOCYTOPENIC thrombotic-hemolytic uremic syndrome
RGG010

CONN SYNDROME
RCG010

Conradi-Hunermann SYNDROME
RNG060

cornea guttata
RFG140

craniosynostosis PRIMARY
RNG040

Crouzon Disease
RNG040

congenital deficiency of coagulation factors
RDG020

DEFICIT OF LECITINCOLESTEROLOACILTRANSFERASI
RCG070

DEFICIENCY FAMILY lipoprotein lipase
RCG070

SUBACUTE CEREBELLAR DEGENERATION
RFG040


RFG130
Terrien marginal degeneration
DEGENERATION SYNDROME NODULE NODULES OF DEGENERATION
RFG130
SALZMANN
CORTICAL CEREBELLAR DEGENERATION medullary
RFG040

spinocerebellar degeneration HOLMES
RFG040
cerebellar atrophy OLIVAR
Dejerine SOTTAS DISEASE
RFG060
hereditary peripheral neuropathies TYPE OF GEORGE III
SYNDROME
RCG160

DISCONDROSTEOSI
RNG060

hereditary thrombophilia
RDG020

Maxillofacial dysostosis
RNG040

DYSPLASIA CRANIOMETAFISARIA
RNG060
OSTEOCONDROPLASIA
diastrophic dysplasia and PSEUDODIASTROFICA
RNG060

epiphyseal dysplasia hemimelia
RNG050

FIBROUS DYSPLASIA DYSPLASIA
RNG060

FRONT-facio-nasal dysplasia
RNG040

MAXILLONASALE
RNG040

spondyloepiphyseal dysplasia LATE
RNG060

Myoclonic Hunt dyssynergia CEREBELLAR ATROPHY
RFG040
SPINODENTATA
COMBINED CORNEAL DYSTROPHY
RFG140

ENDOTHELIAL CORNEAL DYSTROPHY REAR POLYMORPHISMS
RFG140

GRANULAR CORNEAL DYSTROPHY
RFG140
corneal dystrophy GROENOUW TIPO I; DISTROFIA CORNEALE PUNCTATA O NODULARE DI REIS-BUCKLER
DISTROFIA CORNEALE MACULARE
RFG140
DISTROFIA CORNEALE DI GROENOUW TIPO II
DISTROFIA CORNEALE RETICOLARE
RFG140
DISTROFIA LATTICE; AMILOIDOSI CORNEALE
DISTROFIA DEI CONI
RFG110

DISTROFIA IALINA DELLA RETINA
RFG110
GOLMAN-FAVRE MALATTIA DI
DISTROFIA MUSCOLARE OCULO-GASTRO-INTESTINALE
RFG080

DISTROFIA TORACICA ASFISSIANTE
RNG050

DISTROFIA VITELLIFORME DI BEST
RFG110
FUNDUS FLAVIMACULATUS
DISTROFIA VITREO RETINICA
RFG110
RETINOSCHISI GIOVANILE
DISTROFIE STROMALI DELLA CORNEA
RFG140

DISTURBI DEL METABOLISMO INTERMEDIATE OF FATTY ACIDS AND MITOCHONDRIA
RCG070

Duchenne dystrophy
RFG080

ELLIS-Van Creveld Syndrome
RNG060

hereditary hemochromatosis hemochromatosis
RCG100
FAMILY
haemophilia A haemophilia B
RDG020


RDG020

Engelmann Disease OF
RNG060

ERB dystrophy
RFG080

multiple exostoses
RNG050

FABRY DISEASE
RCG080

Fairbank Disease
RNG060
multiple epiphyseal dysplasia
Fanconi anemia Fanconi Pancytopenia
RDG010

favism
RDG010

FRUTTOSEMIA
RCG060

FUCHS ENDOTHELIAL DYSTROPHY OF
RFG140

galactosemia
RCG060

Gaucher Disease
RCG080

GLYCOGENOSIS
RCG060

GOODMAN SYNDROME
RNG030

HALLERMAN-STREIFF SYNDROME
RNG040
dysostosis OCULOMANDIBOLARE
Hartnup Disease
RCG040

HUNTER SYNDROME
RCG140

Hurler Syndrome
RCG140

IMINOACIDEMIA
RCG040

hyperammonemia HEREDITARY
RCG050

Homozygous familial hypercholesterolaemia TYPE IIa
RCG070

Homozygous familial hypercholesterolaemia TYPE IIb
RCG070

IPERISTIDINEMIA
RCG040

congenital adrenal hyperplasia
RCG020

familial hypertriglyceridemia
RCG070

IPERVALINEMIA
RCG040

hypobetalipoproteinemia
RCG070

hypoplasia megakaryocytic IDIOPATHIC
RDG040

Histiocytosis X
RCG150

congenital ichthyosis
RNG070

ICHTHYOSIS hystrix, Curth-Macklin TYPE
RNG070

lamellar ichthyosis RECESSIVE
RNG070
Bullosa Erythroderma ichthyosiform congenital
ICHTHYOSIS HARLEQUIN TYPE
RNG070

X-linked ichthyosis
RNG070

KENNEDY DISEASE
RFG050

Kniest dysplasia
RNG050
DYSPLASIA METATROPICA
KRABBE DISEASE
RFG010

KUFS DISEASE
RFG020

Kugelberg-Welander Disease
RFG050

Landouzy-Dejerine dystrophy
RFG080

Lesch-Nyhan Disease
RCG120

metachromatic leukodystrophy
RFG010

Malabsorption CONGENITAL sucrose, and isomaltose
RCG060

urine disease maple syrup
RCG040

Marinesco-Sjogren Syndrome
RFG040

Maroteaux-Lamy Syndrome
RCG140

McCune-Albright Syndrome
RNG060
BARS DISSEMINATION
MEESMANN FIBROUS DYSTROPHY
OF JUVENILE EPITHELIAL CORNEAL DYSTROPHY RFG140

MIOPATIA CENTRAL CORE
RFG070

MIOPATIA CENTRONUCLEARE
RFG070

MIOPATIA DESMIN STORAGE
RFG070

MIOPATIA NEMALINICA
RFG070

MORQUIO MALATTIA DI
RCG140

NETHERTON SINDROME DI
RNG070

NEUROPATIA ASSONALE GIGANTE
RFG060

NEUROPATIA CONGENITA IPOMIELINIZZANTE
RFG060

NEUROPATIA SENSORIALE EREDITARIA
RFG060

NEUROPATIA TOMACULARE
RFG060
POLINEUROPATIA RICORRENTE FAMILIARE
NEZELOF SINDROME DI
RCG160

NIEMANN PICK MALATTIA DI
RCG080

OMOCISTINURIA
RCG040

OSTEOGENESI IMPERFETTA
RNG060

osteopetrosis
RNG060

hereditary spastic paraplegia
RFG040
STRUMPEL-LORRAINE'S DISEASE
Pelizaeus-Merzbacher Disease
RFG010

PIERRE ROBIN SYNDROME
RNG040

thrombotic THROMBOCYTOPENIC
RGG010
Moschowitz SYNDROME
Refsum Disease
RFG060
EREDOPATIA ATAXIA POLINEURITIFORME
Retinitis Pigmentosa
RFG110
retinal pigment
RETINAL DYSTROPHY Punct ALBESCENS
RFG110
fundus ALBIPUNCTATUS
CHUTORIAN-ROSENBERG SYNDROME
RFG060

ROUSSY-LEVY SYNDROME
RFG060

SANFILIPPO SYNDROME
RCG140

Scheie SYNDROME OF
RCG140

SCHMIDT SYNDROME
RCG030
Autoimmune polyendocrinopathy TYPE II
hereditary spherocytosis
RDG010

campomelic syndrome
RNG050

malabsorption METHIONINE
RCG040

hyperferritinemia-SYNDROME CONGENITAL CATARACT
RCG100

Stargardt Disease
RFG110

STEINERT DISEASE
RFG090

STORAGE POOL DEFICIENCY
RDG030

THALASSEMIA
RDG010

TANGIER DISEASE
RCG070
ALFALIPOPROTEINA
THOMSEN FAMILY OF DEFICIENCY DISEASE
RFG090

Treacher Collins Syndrome
RNG040

thrombasthenia
RDG030

von Eulenburg Disease
RFG090

VON WILLEBRAND DISEASE
RDG020

Werdnig-Hoffman Disease
RFG050

xanthinuria
RCG120

xanthomatosis CEREBROTENDINEA
RCG070

Extreme Curves Leigh D




Here
reported the post I wrote on the blog
PIANETIDIVERSI :

These days are very focused on something that I hope will lead to positive results, for now I just have a terrible sore testa.Sto trying to understand and experience as a result, the effects of vitamin A. For me the vitamin A is very important, this is not to move forward (quickly) my illness and not make the photoreceptors die in my retina.Sto trying to figure out in what quantity and at what dose should be administered instead it is harmful . looking on the internet have made important discoveries, but at the same time a little sconvolgenti.sapevo that vitamin A palmitate has the same effect on all patients with retinitis pigmentosa, because this disease is caused by mutation of several investigations by geni.Nelle some Berson reveals the importance of 15,000 IU of retinol, this assay has blocked the progress of the disease in patients monitored for 12 anni.Un 'other research done by Jacobson subjects with Sorsby's fundus dystrophy (SFD) has shown the positive effect of high dose of retinol (50,000 IU per day), but could not discover the mechanism that produced this effect . The thing that I can not understand is the interaction between foods with vitamin A and retinol palmitate tablets to 15,000 UI.ecco here dietauna normal well-balanced diet usually provides us with approximately 3000 IU of vitamin A daily. Patients treated with vitamin A should avoid overflowing with food particularly rich in vitamin A, in particular with the animal liver contains about 15,000 IU per 100 g, pate and liver sausages (the day which is consumed in the liver, you should avoid taking vitamin A). Other foods rich in vitamin A are: butter (3000UI/100g), cheese and egg yolk (1000UI/100g). In the case of low protein feeding, the risk of hypervitaminosis A is increased because it decreases the rate of blood RBP (Retinol Binding Protein =: binding globulin 95% of the retinol in the blood and transports it to tissues. Retinol bound to RBP is biologically inert). Fruits and vegetables can be taken freely, without exaggerating with carrots, red peppers and spinach, which contain much beta-carotene. Note that by cooking food lose about 30% of their vitamin A. I have also recently read good results with hyperbaric oxygen therapy, but this therapy is still experimental and not all doctors prescribe in cases of retinitis pigmentosa.A level of diet is important to follow a low calorie diet, especially foods that counteract the free radicals: vitamin C, dark-colored fruits such as plums, prunes, blueberries and blackberries, and vegetables such as free radicals cavolo.i fact have a negative impact on the cells that make up the epithelium retinico.Questo post will be updated in the meantime I hope that those who will read it, and patients not interested, they can help in finding the characteristics of vitamin A and its interaction with other foods and vitamin E is needed for assimilation di questa nell'organismo.vi ringrazio anticipatamente

Coupons For Cj Barrymore



QUI POTETE INSERIRE I VOSTRI PRIMI COMMENTI RIGUARDO L'INVENZIONE DI QUESTO BLOG